Postoperative Radiation Treatment Volumes for Left Upper Alveolus Carcinoma
For postoperative radiation in carcinoma of the left upper alveolus, target volumes should include: (1) a composite CTV-P encompassing both geometric expansion around the reconstructed primary tumor bed/surgical defect AND the surrogate pre-operative GTV-P, and (2) a composite CTV-N including geometric expansion around involved nodal regions plus the entire involved nodal level, with bilateral neck coverage typically required for upper alveolar primaries.
Target Volume Delineation Framework
The most recent ESTRO guidelines 1, 2 provide the definitive framework for postoperative oral cavity cancer target volumes, superseding older approaches:
Primary Tumor CTV (CTV-P)
The CTV-P must be created as a composite volume including:
- Surrogate GTV-P reconstruction: Re-create the original tumor volume on the planning CT by registering pre-operative diagnostic imaging (MRI/CT) or using anatomical landmarks to map where the tumor existed before resection
- Surgical bed expansion: Include geometric expansion around the entire surgical defect and/or reconstruction flap
- Both components must be included—this is not an either/or situation 1
Critical pitfall: Approximately 21-23% of patients develop local recurrence after postoperative IMRT for oral cavity cancer 3, 4. The composite volume approach addresses the fact that microscopic disease can exist both at the original tumor margins AND along surgical manipulation planes.
Nodal CTV (CTV-N)
Create a composite nodal volume including:
- CTV-N1 (high-risk): Geometric expansion around surrogate GTV-N (reconstructed involved nodes) PLUS the entire involved nodal level
- CTV-N2 (prophylactic): At-risk nodal levels based on drainage patterns
For upper alveolar carcinoma specifically: This is classified as a non-lateralized oral cavity subsite 2, meaning:
- Bilateral neck treatment is typically required due to midline drainage patterns
- Contralateral neck failures have been documented when unilateral treatment was used 3
- Include bilateral levels Ib, II, III at minimum; consider IV-V based on nodal involvement
High-Risk Volume Coverage
Marginal and out-of-field failures occur in approximately 32% of locoregional recurrences 3. Common sites of geographic miss include:
- Contralateral neck in N2b patients
- High level II/skull base junction
- Regions intentionally spared near parotid in pathologically involved necks
For upper alveolar tumors with infratemporal fossa extension (T4b disease): Include the entire infratemporal fossa compartment in the CTV, as pterygoid plate erosion is a poor prognostic factor 5.
Dose Prescription
Based on NCCN guidelines 6 and recent outcomes data 4:
High-Risk Sites (CTV-P and involved nodal regions)
- Standard risk: 60-66 Gy in 2.0 Gy fractions
- High-risk features (positive/close margins <5mm, extracapsular extension): 60-66 Gy, preferably with concurrent chemotherapy
- Critical threshold: Doses >56 Gy to the primary site show significantly better local control and progression-free survival (p=0.032) 4
Intermediate/Low-Risk Sites (CTV-N2)
- 3D-CRT or sequential IMRT: 44-50 Gy at 2.0 Gy/fraction
- Simultaneous integrated boost IMRT: 54-63 Gy at 1.6-1.8 Gy/fraction 6
Timing
- Begin within 6 weeks of surgery to minimize accelerated repopulation 6
Technical Considerations
- IMRT is preferred for oral cavity cases to spare parotids and reduce xerostomia while achieving adequate coverage
- Deliver ≥1000 cGy per week to counter accelerated tumor repopulation 6
- Avoid exceeding 72 Gy with conventional fractionation (2.0 Gy/fraction) to prevent unacceptable normal tissue injury 6
Risk Stratification for Volume Selection
Expand volumes for:
- Positive or close margins (<5mm post-formalin fixation) 5
- Multiple positive nodes or extracapsular extension
- Perineural, lymphovascular, or bone invasion
- T3-4 disease or pterygoid plate erosion 5
Consider chemotherapy addition when high-risk features present, as this provides the greatest survival benefit (HR=0.55) in the postoperative setting 7.